ArticlePlasma and Urinary Calprotectin Levels in Type 2 Diabetic Patients with Peripheral Arterial Disease
ArticlePlasma and Urinary Calprotectin Levels in Type 2 Diabetic Patients with Peripheral Arterial Disease
ArticleRole of Asymmetric Dimethylarginine and Nitric Oxidein Type 2 Diabetes Mellitus and its Cardiovascular Complications
ArticleRole of Asymmetric Dimethylarginine and Nitric Oxidein Type 2 Diabetes Mellitus and its Cardiovascular Complications
ArticlePlasma Fibrinogen Levels and Peripheral Neuropathy in Type 2 Diabetes Mellitus: A Correlative Study
ArticlePlasma Fibrinogen Levels and Peripheral Neuropathy in Type 2 Diabetes Mellitus: A Correlative Study
ArticleHYPERHOMOCYSTEINEMIA MODULATES VEGF PLASMA LEVELS AND ITS EXPRESSION IN LEUCOCYTES IN HEALTHY SUBJECTS AND IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE AND DIABETES MELLITUS
ArticleHYPERHOMOCYSTEINEMIA MODULATES VEGF PLASMA LEVELS AND ITS EXPRESSION IN LEUCOCYTES IN HEALTHY SUBJECTS AND IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE AND DIABETES MELLITUS
ArticleTHE RELATIONSHIP BETWEEN VASCULAR ENDOTHELIAL GROWTH FACTOR-A SERUM LEVEL AND THE SEVERITY OF DIABETIC PERIPHERAL NEUROPATHY
ArticleTHE RELATIONSHIP BETWEEN VASCULAR ENDOTHELIAL GROWTH FACTOR-A SERUM LEVEL AND THE SEVERITY OF DIABETIC PERIPHERAL NEUROPATHY
ArticleSTUDY OF SERUM S100P LEVEL AND ITS RELATION TO DIABETIC PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES
ArticleSTUDY OF SERUM S100P LEVEL AND ITS RELATION TO DIABETIC PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES